Medical Equipment

Contraceptive Devices Market Forecast 2026: Where the Industry Is Headed

February 3, 2026February 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Contraceptive Devices Market?

The contraceptive devices market has shown significant expansion in recent years. It is anticipated to increase from $13.55 billion in 2025 to $14.4 billion in 2026, registering a compound annual growth rate (CAGR) of 6.3%. The historical growth can be attributed to heightened awareness of family planning methods, government-backed population control initiatives, a rise in unintended pregnancies, the broadening of reproductive health services, and the increased availability of over-the-counter contraceptive items.

The contraceptive devices market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $18.31 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. The foreseen growth can be attributed to several factors, including an enhanced emphasis on reproductive autonomy and women’s health, a heightened need for long-term and easily manageable contraception, the expansion of digital health services and online pharmacy platforms, a rising acceptance of male contraceptive options, and an increase in sexual health programs led by public and non-governmental organizations. Key trends anticipated during this period encompass a greater uptake of long-acting reversible contraceptives, a surge in demand for female-controlled contraceptive methods, increasing approval of non-hormonal contraceptive devices, broadened availability of contraception via online and public avenues, and an intensified focus on offering dual protection against both pregnancy and STIs.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18320&type=smp

What Drivers Are Supporting Technological Adoption In The Contraceptive Devices Market?

The increasing incidence of sexually transmitted diseases is projected to drive the expansion of the contraceptive device market moving forward. Sexually transmitted diseases (STDs) are infections primarily transmitted via sexual contact, impacting various bodily regions and potentially resulting in a range of symptoms and health complications. The increase in sexually transmitted diseases is attributed to factors like heightened sexual activity, insufficient protection, inadequate sexual health education, and challenges concerning access to healthcare and testing. Contraceptive devices, especially condoms, are vital for sexually transmitted diseases as they establish a barrier that minimizes the transmission risk by preventing direct contact with infectious fluids and lesions. As an illustration, in July 2024, a report published by the UK Health Security Agency, a UK-based government agency, revealed 401,800 new STI diagnoses in England in 2023, indicating a 4.7% rise from the 383,789 cases recorded in 2022. Gonorrhea diagnoses saw a 7.5% increase, rising from 79,268 in 2022 to 85,223 in 2023. Concurrently, infectious syphilis diagnoses climbed by 9.4%, increasing from 8,693 in 2022 to 9,513 in 2023. Therefore, the expanding prevalence of sexually transmitted diseases is fueling the growth of the contraceptive device market.

What Segment Types Are Examined In The Contraceptive Devices Market?

The contraceptive devices market covered in this report is segmented –

1) By Product Type: Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices, Sub-Dermal Implants, Others Product Types

2) By Technology: Hormonal Contraceptives, Barrier Contraceptives

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel And Non-Governmental Organization (NGO), Other Distribution Channels

Subsegments:

1) By Male Contraceptive Devices: Male Condoms, Vasectomy Devices, Male Contraceptive Injections, Male Contraceptive Pills

2) By Female Contraceptive Devices: Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices (IUDs), Sub-Dermal Implants, Emergency Contraceptive Devices

3) By Female Condoms: Internal Latex Female Condoms, Non-Latex Female Condoms

4) By Diaphragms And Sponges: Silicone Diaphragms, Latex Diaphragms, Contraceptive Sponges

5) By Vaginal Rings: NuvaRing (And Other Hormonal Vaginal Rings), Non-Hormonal Vaginal Rings

6) By Intrauterine Devices (IUDs): Copper IUDs, Hormonal IUDs, Non-Hormonal IUDs

7) By Sub-Dermal Implants: Hormonal Implants, Non-Hormonal Implants

8) By Other Product Types: Contraceptive Patches, Contraceptive Injections, Contraceptive Pills, Contraceptive Gel And Creams

What Trends Are Projected To Support The Growth Of The Contraceptive Devices Market?

Major companies in the contraceptive device market are introducing innovative products, such as contraceptive vaginal rings, to offer an accessible, low-maintenance birth control method with a monthly insertion. A contraceptive vaginal ring is a flexible, hormone-emitting device placed into the vagina that guards against pregnancy by constantly releasing hormones to impede ovulation and make cervical mucus thicker. For example, in October 2023, Xiromed LLC, a US-based pharmaceuticals firm, released the EnilloRing. The EnilloRing, developed by Xiromed, is a contraceptive vaginal ring that combines etonogestrel and ethinyl estradiol. It is intended for extended use, remaining in place for three weeks. This is followed by a one-week ring-free interval to effectively prevent conception.

Who Are The Primary Competitors In The Global Contraceptive Devices Market?

Major companies operating in the contraceptive devices market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, Pregna International Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Contraceptive Devices Market?

North America was the largest region in the contraceptive devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Contraceptive Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18320&type=smp

Browse Through More Reports Similar to the Global Contraceptive Devices Market 2026, By The Business Research Company

Temperature Sensor Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/temperature-sensor-global-market-report

Patient Temperature Monitoring Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/patient-temperature-monitoring-global-market-report

Patch Management Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/patch-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795